Real-World Effectiveness of Hydrus Microstent and OMNI Surgical System Combined with Phacoemulsification for Open-Angle Glaucoma

What this Trial Is About

This research aims to evaluate how well the combination of Phacoemulsification, OMNI Canaloplasty, and Hydrus Microstent lowers intraocular pressure IOP in patients with Open Angle Glaucoma. The study focuses on a group of ethnically diverse patients who have undergone this combined surgical procedure. Researchers are analyzing real-world data retrospectively to understand the surgerys effectiveness over time. The study involves reviewing data from 300 eyes that received the combined treatment of Phacoemulsification with the OMNI Surgical System and Hydrus Microstent. These procedures are performed together to potentially lower IOP in patients with Open Angle Glaucoma. The analysis looks at the impact of this combined surgical approach on IOP reduction over a follow-up period. Participants are involved through retrospective data collection, including their medication use, eye pressure, and visual field measurements. The main outcome measured is the efficacy of the surgical process combined with Phacoemulsification over 24 months. Additional benefits are also monitored over 36 months. The study ensures thorough follow-up data is available for at least three years, helping researchers assess the long-term impact of the treatment.

Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis